Population
Genetically altered mice and cultured cardiomyocytes (as discussed in the review)
Design
Review
Authors
Loading...
No immediate clinical implications for hypertrophy; leaves open dual pathway targeting for future therapeutic validation.
Calcineurin-NFAT and MAPK signaling pathways are inter-dependent co-regulators of the cardiac hypertrophic response.
Jeffery D. Molkentin (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: